Unipath (UK) reaches settlement with Chefaro:
This article was originally published in Clinica
Unipath (UK) and Chefaro have reached an out-of-court settlement over Unipath's Rapid immunoassay patent, the basis of its ClearBlue One Step home pregnancy test. Settlement is for an undisclosed sum related to Chefaro's sales of its Predictor Dip and Read test and complementary products. Agreement was also reached over Chefaro's new two-piece Predictor Sure Step test.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.